BioLife Solutions to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update on March 16, 2023

Rhea-AI Summary

BioLife Solutions (NASDAQ: BLFS) will release its fourth quarter and full year 2022 financial results after market close on March 16, 2023. The company will also host a conference call at 4:30 PM ET to discuss these results and provide a general business update. Investors can access the call via BioLife's Investor Relations page or by dialing in. The results are critical as they will reflect BioLife's performance in the rapidly evolving cell and gene therapy market, where it supplies bioproduction tools and services. The conference call will also include insights into the company's future outlook.

BOTHELL, Wash., March 9, 2023 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's fourth quarter and full year 2022 financial results will be released after market close on Thursday, March 16, 2023. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free (800) 715-9871 for domestic callers and (646) 307-1963 for international callers. The conference ID number is 3739539. A webcast replay will be available approximately two hours after the call and will be archived on https://www.biolifesolutions.com/ for 90 days.

About BioLife Solutions
BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary CryoStor^® and HypoThermosol^® biopreservation media for shipping and storage, the ThawSTAR^® family of automated, water-free thawing products, evo^® cold chain management system, high capacity cryogenic storage freezers, Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools. For more information, please visit www.biolifesolutions.com and follow BioLife on LinkedIn and Twitter.

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors
LHA Investor Relations
Jody Cain
(310) 691-710
jcain@lhai.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-fourth-quarter-and-full-year-2022-financial-results-and-provide-business-update-on-march-16-2023-301768396.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions report its Q4 and full year 2022 financial results?

BioLife Solutions will report its Q4 and full year 2022 financial results after market close on March 16, 2023.

What time is the conference call for BioLife Solutions financial results?

The conference call for BioLife Solutions' financial results is scheduled for 4:30 PM ET on March 16, 2023.

How can I access the BioLife Solutions results and conference call?

You can access the BioLife Solutions results and conference call through their Investor Relations page or by dialing the provided toll-free numbers.

What is the focus of BioLife Solutions' conference call?

The conference call will focus on financial results for the fourth quarter and full year of 2022, along with a general business update.